TIM MIRUS Controller - Patient Safety Guidelines

2 Safety
IFU, MIRUS Controller, en-GB, N.00 13
2.2 Warning symbols used in the IFU
Caution
Not following this point will lead to damages to the device or the
system.
Warning
Not following this point will lead to patient and/or user harm.
2.3 Patient safety
2.3.1 Monitoring
WARNING For patient safety always use patient cardiovascular monitoring during
operation of the MIRUS System.
Do not use the MIRUS System for spontaneous breathing patients
without an apnoea backup ventilation safety mode.
For patient safety always perform a System test prior to operation.
In case of a non-functioning touch screen always disable the delivery
of anaesthetic by disconnecting the MIRUS Reflector Interface plug.
Always set alarm levels for et VA and et CO
2
according to application
and patient.
2.3.2 Volatile anaesthetic agents (VA)
WARNING Using any other volatile anaesthetic agent than the one your MIRUS
Controller is designed for can result in overdosing and serious patient
injury.
Never use any bypass to the keyed filler system. This can result in
overdosing and serious patient injury.
Do not switch type of volatile anaesthetic agent while treating a patient.